Truth short folly

Somebody, using the name “Jen Lehman” has recently unlawfully pretended to represent “Study in Poland” recruiting students to Polish universities. Beware the person HAS NO RIGHT to use or refer to website survie-fr.info

Browse from more than 400 English study programmes in Poland!

Excellence put unaffected

 

Nay particular delightful

Academic schools

Vocational schools

Study in Poland - programme - survie-fr.info

Pultusk Academy of Humanities

address: ul. Daszyńskiego 17
06-100 Pułtusk, Poland
phone: +48 23 692 98 13-16
e-mail: [email protected]    internet:

Administration

language

Polish

description

Our Curriculum is aligned towards the skill needs of the public administration sector, responds to the expectations of potential employers, and prepares students to achieve their future career success increasing their chances of finding and holding jobs both in the public and in the private sectors. Upon graduation, our alumni are each awarded a Bachelor’s degree /licencjat/. Our Curriculum and the respective Plans of Studies have been developed in compliance with the Learning Standards published by the Ministry of Science and Higher Education. They cover all the components of the learning content that are to be taught over the timeframe of 360 contact hours allotted to the block of compulsory subjects, and over the 220 contact hours allotted to major and elective courses. The total of the class contact hours provided under our Six Semester Program amounts to 1801 for the full-time (regular) studies, and to 1081 for the part-time (extramural) studies. The Curriculum is structured by subject, with a problem-based learning approach.

tuition

Contact the Unit

deadline

Contact the Unit

contact

Faculty of Administrative Studies ul. Daszyńskiego 17 06-100 Pułtusk Tel.: (23) 692 98 25 (to 27) Fax: (23) 691 90 17 e-mail: [email protected]

www

www.ah.edu.pl

institution

Pultusk Akademy of Humanities

education requirements

Contact the Unit

. On the global pharmaceutical market this medicine was issued in 2003 by two companies - Eli Lilly and ICOS. Initially, permission to sell was obtained in Europe, Australia, New Zealand.